Decta-2 5ml

DESCRIPTION

Decta-2 (Decta-2) - eye drops for the treatment and prevention of ophthalmic diseases in dogs and cats. In appearance, Decta-2 is a colorless, transparent, slightly opalescent liquid.

COMPOSITION

Decta-2 as active ingredients in 1 ml contains: gentamicin sulfate - 5 mg and dexamethasone sodium phosphate - 1 mg, as well as auxiliary substances: benzyl alcohol - 9 mg, polyvinylpyrrolidone - 14 mg, sodium chloride - 9 mg and water for injection - up to 1 ml.

PHARMACOLOGICAL PROPERTIES

Decta-2 belongs to the combined antibacterial drugs. The combination of active components included in the preparation provides its bactericidal, anti-inflammatory and anti-allergenic effect.

Gentamicin sulfate is an antibiotic of the aminoglycoside group, active against most gram-negative and some gram-positive bacteria, including Pseudomonas aeruginosa. The mechanism of its bactericidal action is based on the inhibition of peptide bonds during protein synthesis in the ribosomes of a bacterial cell.

Dexamethasone sodium phosphate belongs to the group of synthetic analogs of glucocorticoids, has the ability to inhibit inflammation and allergic reactions of both immediate and delayed types.

When instilled into the conjunctival cavity, the drug easily penetrates into the tissues of the eye, providing a stable therapeutic level of active ingredients.

Dekta-2, according to the degree of impact on the body, belongs to low-hazard substances (hazard class 4 in accordance with GOST 12.1.07-76), in the recommended doses it does not have a local irritating and sensitizing effect.

DOSAGE AND APPLICATION

Dektu-2 is prescribed to dogs and cats with a therapeutic purpose for acute and chronic ophthalmic diseases of bacterial etiology, including conjunctivitis, blepharitis, keratitis, keratoconjunctivitis, iridocyclitis, including those accompanied by allergic reactions, in order to prevent eye diseases after injuries and foreign contact eye surgery in the preoperative and postoperative periods.

Before using Dekta-2, in the presence of abundant discharge from the eyes, a preliminary hygienic treatment is carried out: with a sterile gauze napkin moistened with the drug, the corners of the eyes, eyelids are treated, exudate and dried crusts are removed.

After that, 2-3 drops of the drug are instilled into the conjunctival cavity two to three times a day for 5-10 days until the clinical signs of the disease disappear. If necessary, repeat the course of treatment.

For the prevention of complications when a foreign body and other irritating agents enter the eye, as well as in eye surgery in the preoperative and postoperative periods, the drug is instilled into the animal's conjunctival cavity 1-2 drops three times a day for 3 days.

SPECIAL INSTRUCTIONS

Overdose symptoms have not been identified in animals.

The peculiarities of the action of the drug during the first use and withdrawal have not been established.

Avoid skipping the next dose of the drug, as this can lead to a decrease in therapeutic effectiveness. If one dose is missed, the use of the drug is resumed in the same dosage and according to the same scheme.

Do not use Decta-2 at the same time as corticosteroids.

Decta-2 is not intended for use in productive animals.

CONTRAINDICATIONS

Contraindication to use is individual intolerance to the animal components of the drug (including a history), glaucoma and corneal ulcers.

SIDE EFFECTS

As a rule, side effects and complications in animals when using Dekta-2 in accordance with this instruction are not observed. In case of increased individual sensitivity of the animal to the components of the drug and the occurrence of allergic reactions, its use is discontinued, and, if necessary, the animal is prescribed desensitizing therapy.

SHELF LIFE AND STORAGE

Store the drug in a sealed manufacturer's packaging, in a dry, dark place, separate from food and feed, at a temperature from 0 В° C to 25 В° C.

The shelf life of the medicinal product, subject to storage conditions in the manufacturer's sealed packaging, is 2 years from the date of production, after the first opening of the bottle - 10 days.

PACKAGING

The drug is released in 5 ml packs in sterile polymer vials with a dropper cap.

Vials are individually packed in cardboard boxes complete with instructions for use.

Specifications

KolVUP

ten

Manufacturer

APICENNA

Temperature regime

from 0 to +25

Teaser

eye drops for cats and dogs, for the treatment of allergic conjunctivitis